E
EUREMAB
euremab.eu
Website unreachable since Oct 27, 2026
The startup develops a molecular platform for clinical applications, focusing on the creation of targeted therapies for inflammatory diseases, autoimmune syndromes, metabolic disorders, and degenerative diseases. By addressing conditions that currently lack effective treatments, the company aims to enhance patient outcomes and improve quality of life.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$23.2MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a molecular platform for clinical applications, focusing on the creation of targeted therapies for inflammatory diseases, autoimmune syndromes, metabolic disorders, and degenerative diseases. By addressing conditions that currently lack effective treatments, the company aims to enhance patient outcomes and improve quality of life.